<DOC>
	<DOCNO>NCT02738684</DOCNO>
	<brief_summary>This project aim small sample exploratory study , predict EGFR-TKI target therapy gefitinib ' efficacy late stage lung adenocarcinoma patient ( phase IIIB IV ) , negative tissue EGFR gene mutation , positive plasma free nucleic acid EGFR gene .</brief_summary>
	<brief_title>A Study Predict Gefitinib ' Efficacy Lung Cancer Plasma Free Nucleic Acids EGFR Gene Mutation Test</brief_title>
	<detailed_description>Results study clarify circulate tumor DNA ( ctDNA ) EGFR mutation could use screen method EGFR-TKI target therapy late stage lung cancer patient , well standard therapy efficacy . This study use standard ass gefitinib ' efficacy 8 week treatment IIIB stage IV lung cancer tumor tissue negative , ctDNA positive EGFR mutation .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Participants research must meet following criterion : histologic diagnose lung adenocarcinoma . Late stage ( stage IIIB IV ) lung adenocarcinoma accord International Union cancer ( UICC ) late version standard cancer TNM staging . tumor tissue EGFR mutation negative , ctDNA EGFR mutation positive correlate EGFR TKI sensitivity . Participants sign date official informed consent . Not less 18 year old . At least 1 lesion exactly measure . Patients whose plasma free nucleic acid EGFR mutation test positive , willing use gefitinib therapy expense . Exclusion criterion : Patients already receive EGFRTKI treatment previously . Patients pressure spinal cord brain metastasis , symptom , condition stable , need use steroid medication 4 week start study . Patients clinical evidence symptom severe uncontrolled hypertension , example , researcher believe patient uncontrolled hypertension active bleeding affect study reliability . Patients uncontrolled nausea vomiting , chronic gastrointestinal disease , unable swallow drug underwent major bowel resection may affect full absorption gefitinib . Patients meet one follow heart standard : static State , 3 time ECG check show average correction QT period ( QTc ) &gt; 470 msec ; clinical abnormal symptom rhythm , conduction , static ECG , example completely leave beam conduction block , III degrees conduction block , II degrees conduction block , PR period &gt; 250 msec , various factor risk extend QTc rhythm disorder , example , congestive heart failure , low potassium blood syndrome , congenital long QT Syndrome , direct relative long QT syndrome sudden unexplained death le 40 year old , drug combination may prolong QT interval . Patients Have follow history : ILD , druginduced ILD , radiation Pneumonitis require steroid treatment , clinically active interstitial lung disease . Abnormal marrow reservation organ function . Women breastfeed . Fertile male female , take effective contraceptive measure , woman pregnant breast feeding , positive pregnancy test prior study ( urine serum ) . Patients n't agree study process , constraint requirement , evaluate researcher ca n't participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>EGFR</keyword>
	<keyword>plasma free nucleic acid</keyword>
</DOC>